Advancing Health Equity with MRD: Precision Tools for Personalized Cancer Care

This webinar will provide AMGA members with insights on how minimal residual disease (MRD) testing can support health equity by improving early detection and patient outcomes, and addressing disparities in healthcare access. By incorporating MRD testing into care models, healthcare providers can identify and monitor patients who are at risk, driving more equitable health outcomes.